118 related articles for article (PubMed ID: 28345139)
1. Utility of βhCG monitoring in the follow-up of medical management of miscarriage.
Petersen SG; Perkins AR; Gibbons KS; Bertolone JI; Mahomed K
Aust N Z J Obstet Gynaecol; 2017 Jun; 57(3):358-365. PubMed ID: 28345139
[TBL] [Abstract][Full Text] [Related]
2. Early pregnancy failure: factors affecting successful medical treatment.
Odeh M; Tendler R; Kais M; Maximovsky O; Ophir E; Bornstein J
Isr Med Assoc J; 2010 Jun; 12(6):325-8. PubMed ID: 20928983
[TBL] [Abstract][Full Text] [Related]
3. Predictors of complete miscarriage after expectant management or misoprostol treatment of non-viable early pregnancy in women with vaginal bleeding.
Fernlund A; Jokubkiene L; Sladkevicius P; Valentin L
Arch Gynecol Obstet; 2020 Nov; 302(5):1279-1296. PubMed ID: 32638095
[TBL] [Abstract][Full Text] [Related]
4. Sublingual misoprostol for management of empty sac or missed miscarriage: The first two years' experience at a metropolitan Australian hospital.
Mcgee TM; Diplock H; Lucewicz A
Aust N Z J Obstet Gynaecol; 2016 Aug; 56(4):414-9. PubMed ID: 27323689
[TBL] [Abstract][Full Text] [Related]
5. The medical management of missed miscarriage: outcomes from a prospective, single-centre, Australian cohort.
Petersen SG; Perkins AR; Gibbons KS; Bertolone JI; Mahomed K
Med J Aust; 2013 Sep; 199(5):341-6. PubMed ID: 23992191
[TBL] [Abstract][Full Text] [Related]
6. The value of an initial drop in human Chorionic gonadotropin levels in predicting a response to methotrexate in women with low-risk gestational trophoblastic neoplasia.
Banach P; Zaborowski MP; Izycka N; Romala A; Nowak-Markwitz E
Ginekol Pol; 2019; 90(3):141-147. PubMed ID: 30950003
[TBL] [Abstract][Full Text] [Related]
7. The management of missed miscarriage in an outpatient setting: 800 versus 600 μg of vaginal misoprostol.
Barceló F; De Paco C; López-Espín JJ; Silva Y; Abad L; Parrilla JJ
Aust N Z J Obstet Gynaecol; 2012 Feb; 52(1):39-43. PubMed ID: 22145604
[TBL] [Abstract][Full Text] [Related]
8. Serum biomarkers may help predict successful misoprostol management of early pregnancy failure.
Schreiber CA; Ratcliffe SJ; Quinley KE; Miller C; Sammel MD
Reprod Biol; 2015 Jun; 15(2):79-85. PubMed ID: 26051455
[TBL] [Abstract][Full Text] [Related]
9. Ultrasonographic endometrial thickness after medical and surgical management of early pregnancy failure.
Reeves MF; Lohr PA; Harwood BJ; Creinin MD
Obstet Gynecol; 2008 Jan; 111(1):106-12. PubMed ID: 18165398
[TBL] [Abstract][Full Text] [Related]
10. Medical management of miscarriage: Predictive factors of success.
Lusink V; Wong C; de Vries B; Ludlow J
Aust N Z J Obstet Gynaecol; 2018 Oct; 58(5):590-593. PubMed ID: 29624638
[TBL] [Abstract][Full Text] [Related]
11. Can we use a lower intravaginal dose of misoprostol in the medical management of miscarriage? A randomised controlled study.
Petersen SG; Perkins A; Gibbons K; Bertolone J; Devenish-Meares P; Cave D; Mahomed K
Aust N Z J Obstet Gynaecol; 2013 Feb; 53(1):64-73. PubMed ID: 23106243
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of misoprostol in relation to uterine position in the treatment of early pregnancy failure.
Reif P; Tappauf C; Panzitt T; Haas J; Lang U; Klaritsch P
Int J Gynaecol Obstet; 2013 May; 121(2):137-40. PubMed ID: 23419998
[TBL] [Abstract][Full Text] [Related]
13. Intravaginal misoprostol 600 microg and 800 microg for the treatment of early pregnancy failure.
Kovavisarach E; Jamnansiri C
Int J Gynaecol Obstet; 2005 Sep; 90(3):208-12. PubMed ID: 15967450
[TBL] [Abstract][Full Text] [Related]
14. Performance of plasma kisspeptin as a biomarker for miscarriage improves with gestational age during the first trimester.
Abbara A; Al-Memar M; Phylactou M; Kyriacou C; Eng PC; Nadir R; Izzi-Engbeaya C; Clarke SA; Mills EG; Daniels E; Huo L; Pacuszka E; Yang L; Patel B; Tan T; Bech P; Comninos AN; Fourie H; Kelsey TW; Bourne T; Dhillo WS
Fertil Steril; 2021 Sep; 116(3):809-819. PubMed ID: 34053677
[TBL] [Abstract][Full Text] [Related]
15. [Assessment of efficacy and safety of medical treatment of non-viable first trimester pregnancy].
Zwierzchowska A; Głuszak M; Jabiry-Zieniewicz Z; Banaszek-Wysoczańska A; Dziadecki W; Barcz E
Ginekol Pol; 2012 Oct; 83(10):760-5. PubMed ID: 23383562
[TBL] [Abstract][Full Text] [Related]
16. The impact of introducing medical management on conservative and surgical management for early pregnancy miscarriage.
Black KI; de Vries BS; Moses F; Pelosi M; Cong A; Ludlow J
Aust N Z J Obstet Gynaecol; 2017 Feb; 57(1):93-98. PubMed ID: 28251638
[TBL] [Abstract][Full Text] [Related]
17. Association between uterine position and transvaginal misoprostol treatment for early pregnancy failure.
Chill HH; Malyanker N; Karavani G; Haj-Yahya R; Herzberg S; Bahar R; Shveiky D; Dior UP
J Obstet Gynaecol Res; 2018 Feb; 44(2):248-252. PubMed ID: 29094502
[TBL] [Abstract][Full Text] [Related]
18. Endometrial thickness and serum beta-hCG as predictors of the effectiveness of oral misoprostol in early pregnancy failure.
El-Baradie SMY; El-Said MH; Ragab WS; Elssery KM; Mahmoud M
J Obstet Gynaecol Can; 2008 Oct; 30(10):877-881. PubMed ID: 19038070
[TBL] [Abstract][Full Text] [Related]
19. βhCG monitoring after single-dose methotrexate treatment of tubal ectopic pregnancy: is the Day 4 βhCG necessary? A retrospective cohort study.
Atkinson M; Gupta S; Mcgee T
Aust N Z J Obstet Gynaecol; 2014 Oct; 54(5):475-9. PubMed ID: 25287565
[TBL] [Abstract][Full Text] [Related]
20. Sublingual versus vaginal misoprostol in the management of missed miscarriage.
Shah N; Azam SI; Khan NH
J Pak Med Assoc; 2010 Feb; 60(2):113-6. PubMed ID: 20209697
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
